欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/3441/001
药品名称Calcipotriol/Betamethason Sandoz 50 microgram/0,5 mg/g ointment
活性成分
    • betamethasone dipropionate 0.5 mg
    • calcipotriol monohydrate 50.0 µg
剂型Ointment
上市许可持有人Sandoz B.V. Veluwezoom 22 1327 AH Almere The Netherlands
参考成员国 - 产品名称Netherlands (NL)
Calcipotriol/Betamethason Sandoz 50 microgram/g + 0,5 mg/g, zalf
互认成员国 - 产品名称
    • Germany (DE)
      Calcipotriol comp HEXAL 50 Mikrogramm/g + 0,5 mg/g Salbe
    • Denmark (DK)
    • Belgium (BE)
      CRYSALIS 50 microgram/ 0,5 mg/g zalf
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Sweden (SE)
    • Malta (MT)
      Calcipotriol/Betamethasone Sandoz Ointment 50mcg per g/ 500mcg per g
    • Latvia (LV)
      Cabemet 50 mikrogrami/0,5 mg/g ziede
    • Lithuania (LT)
      Cabemet 50 mikrogramų/0,5 mg/g tepalas
    • Estonia (EE)
      CABEMET
    • Slovenia (SI)
    • Norway (NO)
    • Finland (FI)
    • Italy (IT)
许可日期2015/12/14
最近更新日期2024/04/29
药物ATC编码
    • D05AX52 calcipotriol, combinations
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase